These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7905297)
21. Detection and viability of tumor cells in peripheral blood stem cell and bone marrow collections from breast cancer patients. Salloum E; Reiss M; Cooper D Blood; 1994 Apr; 83(7):2007-8. PubMed ID: 8142668 [No Abstract] [Full Text] [Related]
22. Clonotypic myeloma cells able to xenograft myeloma to nonobese diabetic severe combined immunodeficient mice copurify with CD34 (+) hematopoietic progenitors. Pilarski LM; Belch AR Clin Cancer Res; 2002 Oct; 8(10):3198-204. PubMed ID: 12374689 [TBL] [Abstract][Full Text] [Related]
23. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Franklin WA; Shpall EJ; Archer P; Johnston CS; Garza-Williams S; Hami L; Bitter MA; Bast RC; Jones RB Breast Cancer Res Treat; 1996; 41(1):1-13. PubMed ID: 8932871 [TBL] [Abstract][Full Text] [Related]
24. Selling bone marrow--Flynn v. Holder. Cohen IG N Engl J Med; 2012 Jan; 366(4):296-7. PubMed ID: 22187961 [No Abstract] [Full Text] [Related]
25. [Neoplastic transformation of the pluripotential stem cell. II. Regeneration and differentiation of populations of leukemic blast cells]. Rupniewska ZM Acta Haematol Pol; 1985; 16(1-2):102-8. PubMed ID: 3914169 [No Abstract] [Full Text] [Related]
26. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Gazitt Y; Tian E; Barlogie B; Reading CL; Vesole DH; Jagannath S; Schnell J; Hoffman R; Tricot G Blood; 1996 Jan; 87(2):805-11. PubMed ID: 8555506 [TBL] [Abstract][Full Text] [Related]
27. Bone marrow versus peripheral blood progenitor cells CD34 selection in patients with non-Hodgkin's lymphomas: different levels of tumor cell reduction. Implications for autografting. Lopez M; Lemoine FM; Firat H; Fouillard L; Laporte JP; Lesage S; Isnard F; Stachowiak J; Ferrer-Le Coeur F; Morel P; Najman A; Douay L; Gorin NC Blood; 1997 Oct; 90(7):2830-8. PubMed ID: 9326252 [TBL] [Abstract][Full Text] [Related]
28. [Experimental and clinical use of cell cultures in chronic myeloid leukemia]. Burgaleta C; Soria H; Moreno T Sangre (Barc); 1984; 29(4-B):549-64. PubMed ID: 6393382 [No Abstract] [Full Text] [Related]
29. [The role of stromal and hematopoietic tissue interaction in pathology of hematopoiesis]. Morozova VT Klin Lab Diagn; 2003 Aug; (8):33-6. PubMed ID: 14524126 [No Abstract] [Full Text] [Related]
30. Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants. Kong Y; Song Y; Hu Y; Shi MM; Wang YT; Wang Y; Zhang XH; Xu LP; Liu KY; Deng HK; Huang XJ Oncotarget; 2016 May; 7(21):30892-906. PubMed ID: 27105530 [TBL] [Abstract][Full Text] [Related]
31. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease. de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878 [TBL] [Abstract][Full Text] [Related]
32. The origin of stromal cells in patients treated by bone marrow transplantation. Gordon MY Bone Marrow Transplant; 1988 Jul; 3(4):247-51. PubMed ID: 2901883 [TBL] [Abstract][Full Text] [Related]
33. Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects. Bertolini F; de Vincentiis A; Lanata L; Lemoli RM; Maccario R; Majolino I; Ponchio L; Rondelli D; Tabilio A; Zanon P; Tura S Haematologica; 1997; 82(2):220-38. PubMed ID: 9175330 [TBL] [Abstract][Full Text] [Related]
34. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma. Lemoli RM; Cavo M; Fortuna A J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709 [TBL] [Abstract][Full Text] [Related]
36. The biology and clinical uses of blood stem cells. To LB; Haylock DN; Simmons PJ; Juttner CA Blood; 1997 Apr; 89(7):2233-58. PubMed ID: 9116266 [No Abstract] [Full Text] [Related]
37. Bone marrow and peripheral blood hematopoietic reserve in patients with B-cell chronic lymphocytic leukemia. Pejsa V; Kusec R; Petrovecki M; Jaksic O; Jaksic B; Boranic M Haematologica; 2003 Dec; 88(12):1429-31. PubMed ID: 14688001 [No Abstract] [Full Text] [Related]
38. Liquid marrow serum-free culture in patients acute lymphoblastic leukemia a potential application to purge marrow for autologous transplantation. Douay L; Da WM; Barbu V; Fabrega S; Ozsahin H; Allieri A; Deloux J; Giarratana MC; Drouet X; Van den Akker J Bone Marrow Transplant; 1991; 7 Suppl 2():141. PubMed ID: 1878683 [No Abstract] [Full Text] [Related]
39. Blast colony-forming cell binding from CML bone marrow, or blood, on stromal layers pretreated with G-CSF or SCF. Gidáli J; László E; Halm G; Fehér I Cell Prolif; 2002 Feb; 35(1):1-7. PubMed ID: 11856174 [TBL] [Abstract][Full Text] [Related]
40. Potential and distribution of transplanted hematopoietic stem cells in a nonablated mouse model. Nilsson SK; Dooner MS; Tiarks CY; Weier HU; Quesenberry PJ Blood; 1997 Jun; 89(11):4013-20. PubMed ID: 9166840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]